Crossmark

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia

Crossref DOI link: https://doi.org/10.1016/j.medcle.2022.04.017

Published Print: 2022-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Aomar-Millán, Ismael F.

Salvatierra, Juan

Raya Álvarez, Enrique
License Information

Text and Data Mining valid from 2022-10-01
More Information

This article is maintained by: Elsevier

Article Title: Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2022.04.017

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2022.04.018

Content Type: simple-article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.